95 related articles for article (PubMed ID: 24296283)
1. Mineralocorticoid receptor, the main player in aldosterone-induced large artery stiffness.
Briet M
Hypertension; 2014 Mar; 63(3):442-3. PubMed ID: 24296283
[No Abstract] [Full Text] [Related]
2. Smooth muscle cell mineralocorticoid receptors are mandatory for aldosterone-salt to induce vascular stiffness.
Galmiche G; Pizard A; Gueret A; El Moghrabi S; Ouvrard-Pascaud A; Berger S; Challande P; Jaffe IZ; Labat C; Lacolley P; Jaisser F
Hypertension; 2014 Mar; 63(3):520-526. PubMed ID: 24296280
[TBL] [Abstract][Full Text] [Related]
3. Vascular mineralocorticoid receptor activation and disease.
Barrera-Chimal J; Jaisser F
Exp Eye Res; 2019 Nov; 188():107796. PubMed ID: 31521629
[TBL] [Abstract][Full Text] [Related]
4. Mineralocorticoid-receptor signalling in vascular smooth muscle.
Wu J; Luft FC
Nephrol Dial Transplant; 2013 Jun; 28(6):1360-2. PubMed ID: 23439586
[TBL] [Abstract][Full Text] [Related]
5. Direct contribution of vascular mineralocorticoid receptors to blood pressure regulation.
Barrett KV; McCurley AT; Jaffe IZ
Clin Exp Pharmacol Physiol; 2013 Dec; 40(12):902-9. PubMed ID: 23710823
[TBL] [Abstract][Full Text] [Related]
6. Aldosterone and mineralocorticoid receptors in the cardiovascular system.
Funder JW
Prog Cardiovasc Dis; 2010; 52(5):393-400. PubMed ID: 20226957
[TBL] [Abstract][Full Text] [Related]
7. Extrarenal effects of aldosterone.
Nguyen Dinh Cat A; Jaisser F
Curr Opin Nephrol Hypertens; 2012 Mar; 21(2):147-56. PubMed ID: 22240440
[TBL] [Abstract][Full Text] [Related]
8. Vascular and inflammatory mineralocorticoid receptors in kidney disease.
Barrera-Chimal J; Jaisser F
Acta Physiol (Oxf); 2020 Feb; 228(2):e13390. PubMed ID: 31529757
[TBL] [Abstract][Full Text] [Related]
9. Vascular Consequences of Aldosterone Excess and Mineralocorticoid Receptor Antagonism.
Chrissobolis S
Curr Hypertens Rev; 2017; 13(1):46-56. PubMed ID: 28245785
[TBL] [Abstract][Full Text] [Related]
10. Role of brain corticosterone and aldosterone in central angiotensin II-induced hypertension.
Huang BS; White RA; Ahmad M; Leenen FH
Hypertension; 2013 Sep; 62(3):564-71. PubMed ID: 23856493
[TBL] [Abstract][Full Text] [Related]
11. Low-Dose Mineralocorticoid Receptor Blockade Prevents Western Diet-Induced Arterial Stiffening in Female Mice.
DeMarco VG; Habibi J; Jia G; Aroor AR; Ramirez-Perez FI; Martinez-Lemus LA; Bender SB; Garro M; Hayden MR; Sun Z; Meininger GA; Manrique C; Whaley-Connell A; Sowers JR
Hypertension; 2015 Jul; 66(1):99-107. PubMed ID: 26015449
[TBL] [Abstract][Full Text] [Related]
12. The case against aldosterone: not proven.
Funder JW
Endocrine; 2012 Dec; 42(3):464-5. PubMed ID: 22820892
[No Abstract] [Full Text] [Related]
13. Delineating the receptor mechanisms underlying the rapid vascular contractile effects of aldosterone and estradiol.
Gros R; Ding Q; Davis M; Shaikh R; Liu B; Chorazyczewski J; Pickering JG; Feldman RD
Can J Physiol Pharmacol; 2011 Sep; 89(9):655-63. PubMed ID: 21854125
[TBL] [Abstract][Full Text] [Related]
14. Mineralocorticoid receptor activation: a major contributor to salt-induced renal injury and hypertension in young rats.
Kawarazaki H; Ando K; Fujita M; Matsui H; Nagae A; Muraoka K; Kawarasaki C; Fujita T
Am J Physiol Renal Physiol; 2011 Jun; 300(6):F1402-9. PubMed ID: 21478481
[TBL] [Abstract][Full Text] [Related]
15. Aldosterone-induced EGFR expression: interaction between the human mineralocorticoid receptor and the human EGFR promoter.
Grossmann C; Krug AW; Freudinger R; Mildenberger S; Voelker K; Gekle M
Am J Physiol Endocrinol Metab; 2007 Jun; 292(6):E1790-800. PubMed ID: 17311890
[TBL] [Abstract][Full Text] [Related]
16. Glucocorticoid-related signaling effects in vascular smooth muscle cells.
Molnar GA; Lindschau C; Dubrovska G; Mertens PR; Kirsch T; Quinkler M; Gollasch M; Wresche S; Luft FC; Muller DN; Fiebeler A
Hypertension; 2008 May; 51(5):1372-8. PubMed ID: 18347231
[TBL] [Abstract][Full Text] [Related]
17. Aldosterone induces C-reactive protein expression via MR-ROS-MAPK-NF-κB signal pathway in rat vascular smooth muscle cells.
Zhang X; Liu J; Pang X; Zhao J; Wang S; Wu D
Mol Cell Endocrinol; 2014 Sep; 395(1-2):61-8. PubMed ID: 25109280
[TBL] [Abstract][Full Text] [Related]
18. Aldosterone in vascular and metabolic dysfunction.
Luther JM
Curr Opin Nephrol Hypertens; 2016 Jan; 25(1):16-21. PubMed ID: 26575396
[TBL] [Abstract][Full Text] [Related]
19. Activation of mineralocorticoid receptors in the rostral ventrolateral medulla is involved in hypertensive mechanisms in stroke-prone spontaneously hypertensive rats.
Nakagaki T; Hirooka Y; Matsukawa R; Nishihara M; Nakano M; Ito K; Hoka S; Sunagawa K
Hypertens Res; 2012 Apr; 35(4):470-6. PubMed ID: 22237482
[TBL] [Abstract][Full Text] [Related]
20. Adipocyte-derived factors regulate vascular smooth muscle cells through mineralocorticoid and glucocorticoid receptors.
Nguyen Dinh Cat A; Briones AM; Callera GE; Yogi A; He Y; Montezano AC; Touyz RM
Hypertension; 2011 Sep; 58(3):479-88. PubMed ID: 21788604
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
